相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Production process reproducibility and product quality consistency of transient gene expression in HEK293 cells with anti-PD1 antibody as the model protein
Kai Ding et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
CRISPR-Cas targeted plasmid integration into mammalian cells via non-homologous end joining
Ravichandra Bachu et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives
Jae Seong Lee et al.
BIOTECHNOLOGY JOURNAL (2015)
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Functional knockout of FUT8 in Chinese hamster ovary cells using CRISPR/Cas9 to produce a defucosylated antibody
Tao Sun et al.
ENGINEERING IN LIFE SCIENCES (2015)
Core Fucosylation of IgG B Cell Receptor Is Required for Antigen Recognition and Antibody Production
Wenzhe Li et al.
JOURNAL OF IMMUNOLOGY (2015)
Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
J. Tschui et al.
VIRCHOWS ARCHIV (2015)
CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives
Jae Seong Lee et al.
BIOTECHNOLOGY JOURNAL (2015)
Accelerating Genome Editing in CHO Cells Using CRISPR Cas9 and CRISPy, a Web-Based Target Finding Tool
Carlotta Ronda et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells
Matthew C. Canver et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
Rajat M. Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Therapeutic antibodies: Market considerations, disease targets and bioprocessing
John G. Elvin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Biacore surface matrix effects on the binding kinetics and affinity of an antigen/antibody complex
Andrew W. Drake et al.
ANALYTICAL BIOCHEMISTRY (2012)
Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
D. M. Collins et al.
ANNALS OF ONCOLOGY (2012)
Donor substrate binding and enzymatic mechanism of human core α1,6-fucosyltransferase (FUT8)
Miriam P. Koetzler et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Mammalian cell protein expression for biopharmaceutical production
Jianwei Zhu
BIOTECHNOLOGY ADVANCES (2012)
Marketing approval of mogamulizumab A triumph for glyco-engineering
Alain Beck et al.
MABS (2012)
Highly Efficient Deletion of FUT8 in CHO Cell Lines Using Zinc-Finger Nucleases Yields Cells That Produce Completely Nonfucosylated Antibodies
Laetitia Malphettes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2010)
Cell Engineering and Cultivation of Chinese Hamster Ovary (CHO) Cells
Takeshi Omasa et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immuno-affinity purification from human serum
Carola W. N. Damen et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Variable Contribution of Monoclonal Antibodies to ADCC in patients with chronic lymphocytic leukemia
James Weitzman et al.
LEUKEMIA & LYMPHOMA (2009)
Glycosylation as a strategy to improve antibody-based therapeutics
Roy Jefferis
NATURE REVIEWS DRUG DISCOVERY (2009)
Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance
Mark Barok et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Crystal structure of mammalian α1,6-fucosyltransferase, FUT8
Hideyuki Ihara et al.
GLYCOBIOLOGY (2007)
Protein A chromatography for antibody purification
Sophia Hober et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies
A Iannello et al.
CANCER AND METASTASIS REVIEWS (2005)
Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma
K Mimura et al.
CLINICAL CANCER RESEARCH (2005)
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density
R Niwa et al.
CLINICAL CANCER RESEARCH (2005)
Establishment of FUT8 knockout Chinese hamster ovary cells:: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity
N Yamane-Ohnuki et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Improving the efficacy of antibody-based cancer therapies
P Carter
NATURE REVIEWS CANCER (2001)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
分享论文
